NON HODGKINS LYMPHOMA

Clinical trials for NON HODGKINS LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new NON HODGKINS LYMPHOMA trials appear

Sign up with your email to follow new studies for NON HODGKINS LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 3 Completed 2 Terminated 1

First human test of experimental cancer drug halted

Disease control Terminated

This was an early-stage study to test the safety and find the right dose of a new drug called JBH492. It involved 25 patients whose chronic lymphocytic leukemia or non-Hodgkin's lymphoma had returned or did not respond to previous treatments. The main goal was to see how much of …

Matched conditions: NON HODGKINS LYMPHOMA

Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

NON HODGKINS LYMPHOMA

Get alerted when new NON HODGKINS LYMPHOMA trials appear

First human test of experimental cancer drug halted